HomeVTYX • NASDAQ
add
Ventyx Biosciences Inc
Previous close
$4.98
Day range
$4.61 - $5.13
Year range
$1.87 - $40.58
Market cap
333.46M USD
Avg Volume
957.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 41.77M | -1.84% |
Net income | -38.57M | 0.92% |
Net profit margin | — | — |
Earnings per share | -0.62 | 8.82% |
EBITDA | -41.70M | 1.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 302.58M | -19.72% |
Total assets | 332.08M | -14.67% |
Total liabilities | 25.08M | 42.91% |
Total equity | 307.00M | — |
Shares outstanding | 70.49M | — |
Price to book | 1.14 | — |
Return on assets | -34.25% | — |
Return on capital | -36.32% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -38.57M | 0.92% |
Cash from operations | -47.62M | -54.02% |
Cash from investing | 41.76M | 321.04% |
Cash from financing | 96.18M | 97.72% |
Net change in cash | 90.32M | 7,953.83% |
Free cash flow | -32.06M | -86.37% |
About
Founded
2018
Website
Employees
74